Quick Takeaways
- BAILLIE GIFFORD & CO filed SCHEDULE 13G/A for Moderna, Inc. Common Stock (MRNA).
- Disclosed ownership: 5.3%.
- Date of event: 31 Dec 2025.
BAILLIE GIFFORD & CO - 31 Dec 2025 SCHEDULE 13G/A Report for Moderna, Inc. Common Stock (MRNA)
- Filing Manager
- BAILLIE GIFFORD & CO
- Reporting Manager
- BAILLIE GIFFORD & CO
- Security
- Moderna, Inc. Common Stock
- Symbol
- MRNA
- Shares outstanding
- 388,311,585 shares
- Disclosed Ownership
- 20,580,514 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 09 Feb 2026, 10:48:12 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 30 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BAILLIE GIFFORD & CO disclosed 5.3% ownership in Moderna, Inc. Common Stock (MRNA) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 30 Apr 2025.
- Current filing was accepted on 09 Feb 2026, 10:48.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO | 5.3% | 20,580,514 | 20,033,351 | 0 | Grant Meikle | Manager |